- Home
- DOUG vs PALI Comparison
DOUG vs PALI Comparison
Compare DOUG & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOUG | PALI |
|---|---|---|
| Founded | 1911 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.5M | 240.2M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DOUG | PALI |
|---|---|---|
| Price | $1.85 | $2.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $11.29 |
| AVG Volume (30 Days) | 670.5K | ★ 4.0M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.68 | 97.06 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $955,578,000.00 | $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.41 | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $1.51 | $0.55 |
| 52 Week High | $3.20 | $2.64 |
Technical Indicators
Market Signals| Indicator | DOUG | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 68.84 |
| Support Level | $1.55 | $1.57 |
| Resistance Level | $2.87 | $2.64 |
| Average True Range (ATR) | 0.07 | 0.19 |
| MACD | 0.05 | 0.05 |
| Stochastic Oscillator | 87.70 | 97.42 |
Price Performance
Historical ComparisonAbout DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.